Official Statistics

Antenatal screening standards: data report 2018 to 2019

Data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2018 to 31 March 2019.

Applies to England

Documents

FASP standards data 2018 to 2019

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

IDPS standards data 2018 to 2019

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

SCT standards data 2018 to 2019

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This publication covers the 3 NHS population antenatal screening programmes. These are the:

  • NHS fetal anomaly screening programme (FASP)
  • NHS infectious diseases in pregnancy screening (IDPS) programme
  • NHS sickle cell and thalassaemia (SCT) screening programme

Antenatal screening covers 17 different conditions and is offered to approximately 700,000 pregnant women in England every year.

Main facts

The report shows that:

  • approximately 700,000 pregnant women in England are screened for 17 different conditions each year as part of the three antenatal screening programmes
  • coverage for antenatal SCT screening has steadily increased since 2014 to 2015 and is now at 99.7%
  • there were 341 prenatal diagnosis (PND) procedures carried out in 2018 to 2019 as part of antenatal SCT screening, with 43.2% being completed by 12 weeks + 6 days gestation
  • as part of fetal anomaly screening, 97.0% of women with higher chance results were offered an appointment within 3 working days
  • coverage has remained stable since 2016 to 2017 and is now at 99.7% for HIV, hepatitis B and syphilis screening in 2018 to 2019
  • in 2018 to 2019, 98.9% of babies requiring hepatitis B vaccination received their first dose within 24 hours of birth

Contact the PHE Screening helpdesk with any queries about this publication, making sure you include its full title.

Updates to this page

Published 28 October 2020

Sign up for emails or print this page